Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof

Details for Australian Patent Application No. 2004253868 (hide)

Owner Biogen Idec MA Inc.

Inventors Garber, Ellen A.; Benjamin, Christopher D.; Taylor, Frederick R.; Burkly, Linda C.

Agent Cullens

Pub. Number AU-B-2004253868

PCT Pub. Number WO2005/003175

Priority 60/478,284 13.06.03 US; 60/490,186 24.07.03 US

Filing date 14 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 16 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/003175 Priority application(s): WO2005/003175

16 June 2011 Application Accepted

  Published as AU-B-2004253868

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253869-1- (alkylaminoalkyl-pyrolidin-/piperidinyl) - 2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists

2004253865-Surrogate therapeutic endpoint for antiCTLA-4 based immunotherapy of disease